Skip to main content
Log In
Sign Up
Home
Watchlist
Stocks
Stock Screener
Stock Exchanges
Comparison Tool
Earnings Calendar
By Industry
Stock Lists
Top Analysts
Top Stocks
Corporate Actions
IPOs
Recent IPOs
IPO Calendar
IPO Statistics
IPO News
IPO Screener
ETFs
ETF Screener
Comparison Tool
New Launches
ETF Providers
News
Trending
Articles
Technical Chart
Market Movers
Top Gainers
Top Losers
Most Active
Premarket
After Hours
Market Heatmap
Market Newsletter
Stock Analysis Pro
Collapse
Neurocrine Biosciences, Inc. (BVMF:N1BI34)
Brazil
· Delayed Price · Currency is BRL
Watchlist
Compare
40.32
0.00 (0.00%)
At close: Dec 3, 2025
Overview
Financials
Statistics
History
Profile
Chart
Income
Balance Sheet
Cash Flow
Ratios
KPIs
Annual
Quarterly
TTM
Revenue
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
TTM
Download
Full Width
Fiscal Year
TTM
FY 2024
FY 2023
FY 2022
FY 2021
2012 - 2020
Period Ending
Sep '25
Sep 30, 2025
Dec '24
Dec 31, 2024
Dec '23
Dec 31, 2023
Dec '22
Dec 31, 2022
Dec '21
Dec 31, 2021
2012 - 2020
INGREZZA Revenue
2.47B
2.31B
Log In
Log In
Log In
Upgrade
ONGENTYS and Other Product Revenue
19.70M
17.10M
Log In
Log In
Log In
Upgrade
Total Net Product Revenue
2.66B
2.33B
Log In
Log In
Log In
Upgrade
Royalties Revenue
23.30M
18.60M
Log In
Log In
Log In
Upgrade
Milestones Revenue
-
-
Log In
Log In
Log In
Upgrade
Collaboration and Other Revenue
2.60M
6.10M
Log In
Log In
Log In
Upgrade
Total Collaboration Revenue
25.90M
24.70M
Log In
Log In
Log In
Upgrade
Revenue (Total)
2.68B
2.36B
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source:
Fiscal.ai
.